期刊文献+

ICU多重耐药鲍曼不动杆菌的同源性分析 被引量:3

HOMOLOGY ANALYSIS OF MULTIDRUG-RESISTANT ACINETOBACTER BAUMANNII IN ICU
下载PDF
导出
摘要 目的分析某院重症监护室(ICU)多重耐药鲍曼不动杆菌(MDRAB)的耐药性和同源性。方法11株MDRAB在同一时期分离自ICU患者痰标本、环境物品和医务人员手。运用VITEK2Compact进行抗菌药物敏感试验(MIC),脉冲场凝胶电泳(PFGE)分析菌株的同源性。结果对左氟沙星的耐药率最低(54.5%),其次为哌拉西林/他唑巴坦(81.8%),对其他17种抗菌药物的耐药率均很高(90.9%~100%)。PFGE共分为A、B、C、D4个型,其中A型为主要流行克隆株。结论该院ICU分离的MDRAB对临床常用的抗生素耐药性严重。患者间存在A型MDRAB克隆株的交叉感染。 Objective To investigate the drug resistance and the homology of multidrug - resistant Acineto- bacter baumannii (MDRAB) isolated from an intensive care unit (ICU). Methods Eleven strains of MDRAB were isolated from ICU at the same time. The antimicrobial susceptibility were determined by using the Vitek -2 Compact System, and the homology of the strains was analyzed by PFGE. Results All the MDRAB isolates were showed high resistant to seventeen antimicrobial compounds (90.9% to 100% ). 54.5% of the MDRAB isolates were resistant to ciprofloxaein, and 81. 80/0 of the MDRAB isolates were resistant to piperacillin/tazo- bactam. Eleven MDRAB strains were classified into 4 types based on PFGE pulsotypes, named type A, B, C and D. Isolates of type A were the main epidemic strains. Conclusion The drug resistance rate of MDRAB isolated from ICU is high. There has been clonal spread of type A stains among patients.
出处 《现代医院》 2015年第6期89-91,共3页 Modern Hospitals
基金 广州市卫生局医药卫生科技项目(编号:20141A010051)
关键词 鲍曼不动杆菌 脉冲场凝胶电泳 同源性 Acinetobacter baumannii Pulsed field gel electrophoresis(PFGE) Homology
  • 相关文献

参考文献10

二级参考文献79

  • 1张樱,陈亚岗,杨青.不动杆菌感染及耐药机制的研究进展[J].国外医学(流行病学.传染病学分册),2005,32(2):109-112. 被引量:93
  • 2王金良.密切注视鲍曼不动杆菌的耐药发展趋势[J].中华检验医学杂志,2005,28(4):355-356. 被引量:194
  • 3刘皈阳,张梅,王睿,裴斐,方翼.大环内酯类抗菌药物对加替沙星透过细菌生物被膜的影响[J].中华医院感染学杂志,2005,15(7):725-727. 被引量:18
  • 4张小江,徐英春,俞云松,杨青,汪复,朱德妹,倪语星,孙景勇,孙自镛,简翠,胡云建,艾效曼,张泓,李万华,贾蓓,黄文祥,王传清,王爱敏,魏莲花,吴玲,卓超,苏丹虹,张朝霞,季萍,徐元宏,熊自忠,沈继录,单斌,杜艳.2009年中国CHINET鲍曼不动杆菌细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):441-446. 被引量:137
  • 5Arias CA,Murray BE.Antibiotic-resistant bugs in the 21st century-a clinical super-challenge[J].N Engl J Med,2009,360(5):439-443.
  • 6Clinical and Laboratory Standads Institute.Performance Standards for Antimicrobial Susceptibility Testing[S].Fifteenth Informational Supplement,2010,M100-S20 Vol 30 No.1.
  • 7Clinical and Laboratory Standads Institute Performance Standards for Antimicrobial Susceptibility Testing[S].Fifteenth Informational Supplement,2010,M100-S20-U Vol 30 No 15.
  • 8Clinical Laboratory Standard Institute.Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria[S].Approved Guideline M45-A,Vol.26 No.19,2006.
  • 9Wang P,Hu FP,Xiong ZZ,et al.Susceptibility of ESBL-Producing nterobacteriaceae with the New CLSI Breakpoints[J].J Clin Microbiol,2011,49(6):3127-3131.
  • 10Yang Q,Wang H,Sun H,et al.Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems:results from large hospital-based surveillance studies in China[J].Antimicrob Agents Chemother,2010,54(1):573-577.

共引文献818

同被引文献14

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部